Peripheral Blood Monocyte-Derived Immature Dendritic Cells, Fresh

$638
In stock
SKU
Category: Peripheral Blood
Select SKU Size / Day Price
PBIDC01.5F 1.5 million/vial $638 USD
-
+
Questions about shipping? See Shipping Info
Questions? Contact Sales:
530-303-3828
Contact Us
Product Description
Dendritic cells (DCs) form a critical interface between innate and adaptive immunity. DCs continuously sample their environment for antigens by means of endocytosis. Referred to as an antigen-presenting cell (APC), DCs capture, process and present these antigens to naïve T-helper cells to initiate an immune response. There is great heterogeneity in DC phenotypes due to their stage of differentiation or according to their response and interaction with cytokines and/or growth factors in their microenvironment. This can make isolating a specific subset of DCs challenging. Additionally, each subset is rare in number, compounding the difficulty in isolating these cells. Culturing of CD14+ monocytes in the presence of specific growth factors and cytokines can induce differentiation into immature DCs (iDC), known as monocyte-derived immature dendritic cells (MoDCs). Cultured immature dendritic cells remove the phenotype heterogeneity issue as well as the rarity of these cells.

Human peripheral blood monocyte-derived immature dendritic cells are derived from negatively selected monocytes. Non-monocytes are labeled and depleted from the peripheral blood mononuclear cell population using immunomagnetic particles leaving purified, untouched monocytes. Untouched monocytes are cultured for 4-5 days in culture medium containing 10% FBS plus GM-CSF and IL-4. After culture, cells are checked for the expression of CD11c, HLA-DR, and CD83 and the lack of CD14 expression by flow cytometry.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
More Information
Species Human
Disease State Healthy
Cell and Tissue Source Peripheral Blood
Product Type Primary Cells
Cell Type Dendritic Cells
Donor Attributes HIV-, HepB-, HepC-
Purity ≥90% CD11c and MHCII by flow cytometry<30% CD83 ≤5% CD13 by flow cytometry
Viability ≥85% by Flow Cytometry
Format Fresh
Contains PBS with 5% FBS and 0.5% BSA
Anticoagulant ACD-A

Product Information Sheet

Certificate of Analysis

Material Safety Data Sheet

Hi, have questions?

A StemExpress Expert is happy to help!

Call 530.303.3828 or Contact Us